Therapy of acute gastroenteritis: role of antibiotics I. Zollner-Schwetz, R. Krause  Clinical Microbiology and Infection  Volume 21, Issue 8, Pages 744-749 (August 2015) DOI: 10.1016/j.cmi.2015.03.002 Copyright © 2015 European Society of Clinical Microbiology and Infectious Diseases Terms and Conditions

Fig. 1 Management of community-acquired diarrhoea. Note that Shiga toxin-producing Escherichia coli (STEC) infection should be suspected in patients with bloody diarrhoea, abdominal pain or tenderness in the absence of fever. Antimicrobial therapy is not recommended for patients with suspected or proven STEC infection. Clinical Microbiology and Infection 2015 21, 744-749DOI: (10.1016/j.cmi.2015.03.002) Copyright © 2015 European Society of Clinical Microbiology and Infectious Diseases Terms and Conditions

Fig. 2 Management of travellers' diarrhoea (adapted from [19]). Antibiotic treatment is warranted in cases of moderate to severe diarrhoea (more than four stools per day, fever, or blood or mucus in the stool). In travellers with severe symptoms accompanied by fever, azithromycin is the treatment of choice, because of the lack of a systemic effect of rifaximin and increasing resistance to fluoroquinolones, especially in Campylobacter species. Clinical Microbiology and Infection 2015 21, 744-749DOI: (10.1016/j.cmi.2015.03.002) Copyright © 2015 European Society of Clinical Microbiology and Infectious Diseases Terms and Conditions